Építés alatt – nem éles oldal
Belépés

What researchers published on Akut mieloid leukémia (AML)

4392 papers, newest first.

Showing 20 of 4392

  • EsetismertetésPulmonary embolism as the initial manifestation of acute promyelocytic leukemia: A case report and review of the literature.Medicine
  • Not labelled yetNext-Generation Sequencing in Acute Myeloid Leukemia: Advancing Clinical Insights.Anti-cancer agents in medicinal chemistry
  • Not labelled yetNeither the pan-immune-inflammation value nor the PILE score improved on APACHE-II or SOFA in a single-center cohort of critically ill older patients with acute myeloid leukemia.Frontiers in medicine
  • Not labelled yetNPM1-mutated AML: One entity, multiple layers of heterogeneity.British journal of haematology
  • Not labelled yetExpression patterns of hypoxia signaling pathway genes and their association with clinical biochemical parameters in acute myeloid leukemia patients of Assam: A case control study.Molecular biology reports
  • Not labelled yetRare variants of NPM1 mutations share a similar molecular background to the common NPM1 type A variant and are associated with similar survival in adults with acute myeloid leukaemia.British journal of haematology
  • Not labelled yetPhenanthridone derivative PTD031 exerts efficacy against acute myeloid leukemia through dual targeting of DNA and redox homeostasis.Bioorganic chemistry
  • Not labelled yetBCR::ABL1 emergence during menin inhibitor therapy in two patients with relapsed or refractory acute myeloid leukemia.Leukemia & lymphoma
  • Not labelled yetHow I treat MDS/AML: individualizing therapy based on disease biology, patient fitness, molecular features, and treatment goals.Clinical advances in hematology & oncology : H&O
  • ÁttekintésAdvances in CBFA2T3::GLIS2 fusion gene in pediatric acute myeloid leukemia: from molecular mechanisms to targeted therapeutic strategies.Annals of hematology
  • Not labelled yetADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.Cancer medicine
  • Not labelled yetLessons and limitations of the PARADIGM trial in acute myeloid leukemia.Clinical advances in hematology & oncology : H&O
  • EsetismertetésCutaneous polyarteritis nodosa preceding acute myeloid leukemia with plasmacytoid dendritic cell differentiation and leukemia cutis.JAAD case reports
  • Not labelled yetSafety and feasibility of peripherally inserted central catheter (PICC) placement in patients with newly diagnosed acute leukemia: A single-center retrospective study.Annals of hematology
  • MetaanalízisEfficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
  • Not labelled yetDifferential regulation of PRSS57 by tyrosine kinase inhibitors and ATRA in myeloid leukaemia cells: an in vitro study.Journal of applied genetics
  • ÁttekintésSafety and efficacy of immune checkpoint inhibitors and hypomethylating agents in treatment-naïve AML and HR-MDS: a systematic review and HR-MDS meta-analysis.Cancer treatment and research communications
  • Áttekintés[Treatment of acute myeloid leukemia in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Not labelled yetLuteolin reduces cytarabine-resistant acute myeloid leukemia cell proliferation through the GSK3β/Nrf2 pathway.Cytotechnology
  • Not labelled yetRisk of subsequent primary acute myeloid leukemia after breast cancer: A population-based analysis of 608,268 women in the SEER Program.Leukemia research